SCHEMBL5863647

SCHEMBL5863647

Cc1cc(C)c(S(=O)(=O)N(Cc2ccc(O)cc2Cl)c2ccc(I)cc2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 2/20 0.39
NR3C1 P04150 2/20 0.37
PGR P06401 2/20 0.37
NR3C2 P08235 2/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
KEAP1 Q14145 5/20 0.37
NFE2L2 Q16236 3/20 0.37
CYTH2 Q99418 1/20 0.36
RORC P51449 1/20 0.36
GAA P10253 2/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
GFER P55789 1/20 0.34
CYP19A1 P11511 1/20 0.34
ESR1 P03372 1/20 0.33
EPHX2 P34913 1/20 0.32
HTT P42858 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864026 0.84 KEAP1 (0.39) RAPGEF4NR3C1PGRNR3C2NR1H2
SCHEMBL5863634 0.83 NR1H2 (0.38) RAPGEF4NR3C1PGRNR3C2NR1H2
SCHEMBL5864114 0.80 RAPGEF4 (0.41) RAPGEF4NR3C1KEAP1NFE2L2ESR1
SCHEMBL5864051 0.78 ABL1 (0.40) NR1H2NR1H3ESR1HSP90AA1HSP90AB1
SCHEMBL5864216 0.76 SIGMAR1 (0.40) NR1H2NR1H3KEAP1NFE2L2
SCHEMBL5864868 0.76 SIGMAR1 (0.38) GAAEPHX2HTT
SCHEMBL5863517 0.75 TP53 (0.31) RAPGEF4NR1H2NR1H3GAATSHR
SCHEMBL5864171 0.74 HRH3 (0.37)
SCHEMBL6705577 0.74 SLC40A1 (0.33) NR1H2NR1H3KEAP1NFE2L2GAA
SCHEMBL6705581 0.74 GLA (0.39) NR1H2NR1H3KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
EP-1542967-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR Pfizer Products Inc. (US) 2005-06-22 EP disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed
WO-2004026823-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR PFIZER PRODUCTS INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 RAPGEF4 973/4885NR3C1 160/4885PGR 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.